Literature DB >> 10656212

Hepatocellular carcinoma in Belgium: clinical and virological characteristics of 154 consecutive cirrhotic and non-cirrhotic patients.

G Van Roey1, J Fevery, W Van Steenbergen.   

Abstract

OBJECTIVE: This study analyses the characteristics of patients with hepatocellular carcinoma (HCC) in a low endemic area with special emphasis on the differences between cirrhotic and non-cirrhotic patients. DESIGN AND
SETTING: The files of 154 consecutive patients with HCC observed in a single tertiary care hospital have been investigated to determine epidemiological parameters and diagnostic procedures.
RESULTS: Compared to non-cirrhotic cases, cirrhotic patients with HCC are older and have a more pronounced male predominance. Their disease is more advanced, they usually present with multi-focal tumours, rarely located in the left liver lobe. Antibodies to hepatitis C (anti-HCV) are present in 55%, 52% ever had contact with hepatitis B (HBV) and 31% were hepatitis B surface antigen (HBsAg)-positive. Six non-cirrhotic cases were anti-HCV-positive. alpha-Fetoprotein (AFP) elevation > 50 and > 400 microg/l was more frequently observed in cirrhotic patients with HCC (P = 0.016). A striking association was found between enhanced AFP levels and the presence of anti-HCV (P = 0.0006), while no such relation existed for AFP and HBV markers. The sensitivity of a 'routine' ultrasound examination is disappointing for the early detection of HCC in cirrhotic patients.
CONCLUSIONS: In our hospital, in a low endemic area for HCC, we have a surprisingly high proportion of non-cirrhotic patients with HCC (40%). In cirrhosis, usually the consequence of alcohol abuse or hepatitis B or C, small tumours can be missed by ultrasonography if not specifically looked for. AFP levels are particularly elevated in hepatitis C-induced HCC.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10656212

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  6 in total

1.  Clinical characteristics and outcome of a cohort of 101 patients with hepatocellular carcinoma.

Authors:  C Rabe; T Pilz; C Klostermann; M Berna; H H Schild; T Sauerbruch; W H Caselmann
Journal:  World J Gastroenterol       Date:  2001-04       Impact factor: 5.742

2.  Focal nodular hyperplasia of the liver in men: is presentation the same in men and women?

Authors:  A Luciani; H Kobeiter; P Maison; D Cherqui; E-S Zafrani; D Dhumeaux; D Mathieu
Journal:  Gut       Date:  2002-06       Impact factor: 23.059

3.  Epidemiology and survival of patients with hepatocellular carcinoma in Southern Germany.

Authors:  Gabriele Kirchner; Georgi Kirovski; Alexandra Hebestreit; Jürgen Schölmerich; Hans Jürgen Schlitt; Oliver Stoeltzing; Claus Hellerbrand
Journal:  Int J Clin Exp Med       Date:  2010-06-10

4.  Viral hepatitis and hepatocellular carcinoma.

Authors:  Peter P Michielsen; Sven M Francque; Jurgen L van Dongen
Journal:  World J Surg Oncol       Date:  2005-05-20       Impact factor: 2.754

5.  Comparative diagnostic efficacy of serum squamous cell carcinoma antigen in hepatocellular carcinoma.

Authors:  Olufemi Michael Soyemi; Jesse Abiodun Otegbayo; Samuel Olawale Ola; Adegboyega Akere; Temitope Soyemi
Journal:  BMC Res Notes       Date:  2012-08-03

Review 6.  Critical reappraisal of risk factors for occurrence of hepatocellular carcinoma in patients with hepatitis C virus.

Authors:  Savino Bruno; Daniela Savojardo; Piero L Almasio; Mario U Mondelli
Journal:  Hepat Med       Date:  2011-03-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.